The company says the Elekta Infinity linear accelerator is the only one of its kind for pets in England.
It features a multi-leaf collimator for very accurate shaping of the radiation beam and a six-degrees-of-freedom couch top designed so the patient can be positioned to reduce or eliminate radiation doses to critical organs.
CVS says the new machine will allow the centre to offer cutting edge treatments such as stereotactic radiation therapy, where high dose rates of focused beams are delivered with high precision over a shortened treatment course.
This, the company claims, will mean fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital will be at the forefront of cancer care in animals.
“The linear accelerator is state of the art, and allows us to offer advanced, image-guided radiation treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage to these treatments is that they will allow a more “hard-hitting” treatment of the tumour, with greater safety for the patient’s healthy tissue.
"It will draw many tumours into the realm of treatability.”
Based at Central Park, Avonmouth, Bristol Vet Specialists referral hospital is due for completion this Autumn.
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
The course starts in October 2019 and lasts 12 months.
The programme is based around nine days of expert-led small group hands-on practical sessions at CPD Solutions' Training Centre near Birmingham, where participants will develop their existing dentistry skills and learn new techniques.
The company says decision-making is a key focus, as is reflective application of new skills in practice.
CPD Solutions says its PgCerts have unique benefits and differences from other options available, specifically that:
its courses have a stronger emphasis on practical training with all attendance sessions of a practical nature, and no lecture days.
its attendance days are grouped into three sessions rather than the more common monthly attendance.
its programme runs for 12 months, as opposed to many of the alternatives which run for 2-5 years.
Susie Coughlan, Managing Director at CPD Solutions, said: "Our experience is that vets get the most out of hands-on practical training in a structured and supportive environment, combined with reflective application of their new skills in practice.
"We set out to replicate this with the new PgCert in Small Animal Dentistry – all attendance sessions are practical, and the course provides support for developing reflective work-based learning that vets can then use throughout their careers. The format is in keeping with the RCVS CPD focus on outcomes based learning and critical reflective practice."
For more information, ring 0151 328 0444 or visit www.pgcertdent.com
The £11m project, which is backed by Mars Petcare, will include a cutting-edge imaging suite, state-of-the-art treatment facilities and a new linear accelerator.
Plans also include separate cat and dog waiting areas and client walking and comfort areas, seven operating theatres, 15 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and plans for a future hydrotherapy suite.
Daniel Hogan, operations manager at Southfields (pictured right), said: "This is a really exciting time for Southfields and our relocation will provide the region with one of the largest and best-equipped veterinary centres in the UK.
"The team and expertise have grown significantly in the past 18 months. We are very excited to continue to expand the unique and innovative offerings in patient care at our centre.
"Increasing in size will also enable us to provide a dedicated staff wellbeing area and an education centre and lecture hall, which will offer some very exciting qualifications and courses for the wider profession.
"Since our rebranding in 2017, we pride ourselves on leading the industry as a truly multidisciplinary centre with specialists from across the globe, including one of the most illustrious oncology teams in the country. Once this new site is launched, we will be able to offer an even more comprehensive service to our clients and patients."
For more information about Southfields, visit www.southfields.co.uk.
Hill's Pet Nutrition is offering a series of free webinars about feline medicine, delivered by some of the best-known experts in the field.
The first presentation on feline liver disease will be delivered by Danièlle Gunn-Moore BVM&S BSc PhD MACVSc MRCVS, on the 26th January 2011. Martha Cannon BA VetMB DSAM(fel) MRCVS (pictured right) will present the next two webinars on Renal disease on 2nd March and Chronic Diarrhoea on 4th May. Both speakers are RCVS Specialists in feline medicine. Norman Johnston BVM&S, Dipl. AVDC, Dipl. EVDC, MRCVS, will be discussing stomatitis in the cat - a particularly problematic disease - on the 18th May. Norman is an RCVS, American and European Specialist in Veterinary Dentistry. The series will end on 8th June with Duncan Lascelles BSc, BVSc, PhD, CertVA, DSAS (ST), DECVS, DACVS, Associate Professor in Small Animal Surgery at North Carolina State, talking about osteoarthritis in the cat.
The events kick off at 8.30 pm and are hosted by the Webinar Vet (www.thewebinarvet.com). One initial registration provides access to the complete series, with scheduled e-mail reminders sent out prior to the latest webinar. To register, go to www.thewebinarvet.com/hills and enter your details as well as the code hillsnl.
Webinars are ideal for time pressed individuals who may not always be able to travel to a distant venue, yet still offer a 'real- time' and interactive experience. No special equipment is required, other than a reasonable standard PC or MAC and a broadband connection. The events are open to both vets and nurses but early registration is advisable to take full advantage of the whole Hill's Feline webinar series.
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
Ceva says the course is aimed at vets and nurses who want to build their confidence and take the lead in finding hypertension in cats in their clinic.
The course is hosted by Sarah Caney BVSc DSAM(Feline) MRCVS, one of the UK's leading specialists in feline medicine, and will cover things like finding out which cats need screening for feline hypertension, how to become confident in recommending a blood pressure check to owners, hints and tips on taking a reliable blood pressure measurement and handling cats calmly to reduce ‘situational hypertension’.
The course consists of four 30-minute recorded sessions including course notes and self-assessment questions for each module. Once completed, the delegate will receive a Hypertension Ambassador pin badge and a certificate for four hours’ CPD. The first 500 delegates to complete the course will be offered either a cat hide or an eye atlas.
The course can be completed online at any time. There are also weekly feline hypertension live sessions at 1pm, from Wednesday 4th March until Wednesday 25th March. They offer the opportunity for you to ask questions, but they're also recorded so you can watch them any time thereafter.
Suzanne Page BVSc MRCVS, cardio-nephrology-hypertension product manager at Ceva Animal Health, said: "Our HypertensionAmbassadors’ initiative will educate veterinary professionals on every aspect of feline hypertension to enable them to confidently talk to their clients about the condition, measure blood pressure in a cat-friendly way and offer advice on the different treatments available."
For more information, and to register, visit www.veterinarywebinars.com/feline-hypertension-ambassador.
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
The study, which was led by Robert Hyde MRCVS from the School of Veterinary Medicine and Science at the University of Nottingham, aims to create an automated diagnostic support tool for the diagnosis of herd level mastitis origin, an essential first step of the AHDB mastitis control plan.
Mastitis data from 1,000 herds’ was inputted for several three-month periods. Machine learning algorithms were used to classify herd mastitis origin and compared with expert diagnosis by a specialist vet.
The machine learning algorithms were able to achieve a classification accuracy of 98% for environmental vs contagious mastitis, and 78% accuracy was achieved for the classification of lactation vs dry period environmental mastitis when compared with expert veterinary diagnosis.
Robert said: “Mastitis is a huge problem for dairy farmers, both economically and in welfare terms. In our study we have shown that machine learning algorithms can accurately diagnose the origin of this condition on dairy farms. A diagnostic tool of this kind has great potential in the industry to tackle this condition and to assist veterinary clinicians in making a rapid diagnosis of mastitis origin at herd level in order to promptly implement control measures for an extremely damaging disease in terms of animal health, productivity, welfare and antimicrobial use."
Reference
The kit contains the ergonomically designed Henke-Sass Wolf injector with an adjustable dose selector, five single piece Intranasal RSP nozzles – with ‘luer’ lock attachment, which supports easier removal, cleaning and/or replacement – and instructions for use.
For more information, contact your local MSD Animal Health account manager.
The company announced last month that from 1st January next year, practices will have to order companion animal and ruminant products via either MWI or NVS (who will also fulfil the order), but will be invoiced direct by MSD.
Pig products will join aquaculture and poultry products to be supplied directly to customers by MSD Animal Health.
In its announcement, the company said that the new structure would allow the company to enhance the customer experience and more quickly adapt to changes in the market to better serve its customers.
VetSurgeon.org contacted the company for further clarification about how the customer experience would be improved.
The company explained that the two main benefits of the new structure concern price visibility and stock control.
A spokesperson for the company said: "Currently, customers may get a discount from us and separately a discount from wholesaler. With our new distribution model we will invoice monthly and all discounts will be on one invoice, so it will be easier to determine the actual price paid."
The spokesperson explained that with the old model, once stock was sold to wholesalers it would be allocated to customers, so there would be some held by MSD, some allocated and some in distribution: "The benefit of the new model is we will have full oversight of stock as it will be in our own warehouses or with distribution partners. If there are disruptions in the market, we will have better awareness of in market demand and we can allocate stock appropriately".
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
Petplan is calling for nominations for this year's 'Petplan Veterinary Awards 2011'.
The awards, which are now into their 12th year, are an opportunity for colleagues and pet owners to thank their local veterinary stars who go above and beyond the call of duty.
Alison Andrew, Petplan's Marketing Manager, said: "At Petplan, we work closely with vets and hear first hand about the incredible work that is carried out by the profession, so we believe that their invaluable care and support deserves special recognition. Nominating a colleague for an award is a fantastic way of expressing your appreciation for their hard work."
Alison added: "Last year, Petplan was inundated with over 1,800 nominations from across the UK, highlighting that more pet owners understand the great work vets do to help animals and their owners, and with 40% of pet-owners in the UK, stating that they trusted their vet more than their GP, it is not hard to see why the awards are so highly commended."
Closing date for entries is 4th February 2011. All finalists will be invited to a glittering awards ceremony in Birmingham on 31st March 2011, where the winners will be announced.
Winners will be selected based on the evidence given on the nomination forms by veterinary association presidents, so make sure you provide as much information as possible. To nominate today visit www.petplan.co.uk/vetawards
Vets Now Referrals has launched a new specialist veterinary referral service to serve Aberdeen and the North.
Richard Coe MA VetMB CertSAS DipECVS MRCVS (pictured right) and Professor Stuart Carmichael BVMS MVM DSAO MRCVS will attend Ardene House Veterinary Hospital in Aberdeen on a monthly rotational basis to offer specialist care to pets from the area. Richard is a European Specialist in Small Animal Surgery and Professor Carmichael is an internationally recognised expert in veterinary orthopaedics.
By bringing these two specialist surgeons to Aberdeen, it will mean that vets can refer their clients to have their initial consultations and diagnoses locally by either Richard or Stuart, reducing the need for a lengthy journey to Vets Now Referrals in Glasgow where they are usually based. Vets Now says that where possible, treatment plans will be carried out in Aberdeen, however complex treatments may require the facilities and high tech equipment at its Glasgow Hospital.
Any vet wishing to make an enquiry about referring to Richard or Stuart should call 01224 478 041. Further information about the service can also be found on www.vetsnowreferrals.com/aberdeen.
Tricia Colville, Hospital Manager of Vets Now Referrals, Glasgow, said: "We are delighted to now be able to offer our specialist service for vets in the North of Scotland to utilise for their clients. The Vets Now Referrals Hospital in Glasgow has been so successful since it opened over a year ago, benefiting hundreds of pets and their owners. Bringing the service to Aberdeen and the surrounding region will provide vets with local access to Richard Coe and Professor Stuart Carmichael who are both renowned in their fields and for their clients this provides a convenient option which will greatly reduce time-consuming, distressing and costly journeys for them."
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
The study1 took the form of an online survey of over 5,500 owners, which exploring the the early socialisation, health and behaviour of ‘pandemic puppies’ purchased in 2020 compared to 2019 puppies.
The study found that puppies bought during the pandemic in 2020, in comparison to pre-pandemic in 2019, were more likely to have been ‘designer crossbreeds’, for example a Cockapoo or Cavapoo, instead of Kennel Club registered purebred dogs.
The 2020 cohort of pandemic puppies were also more likely to already hold a pet passport at purchase, indicating they may have been imported from Europe – perhaps illegally – to meet the greatly increased demand and prices for puppies.
Amongst the positive findings was the fact that many of the health and socialisation experiences examined didn’t vary significantly between puppies purchased in 2019 and 2020.
However, researchers say there was still a concern that 2020 ‘pandemic puppies’ were less likely than 2019 puppies to attend puppy training classes or to have experienced visitors to their homes (under the age of 16 weeks in both circumstances).
This, they say, means pandemic puppies may be more likely to experience stranger-related fear and anxiety and other behavioural problems related to insufficient socialisation, from being unable to attend puppy classes under 16 weeks of age; a critical period for the development of puppies.
In addition, those puppies sourced from Europe may have been transported over long distances without their mother, a stressful experience which the researchers say could cause problem behaviours in the future.
Pandemic puppies may therefore need extra support from the veterinary profession, particularly those specialising in animal behaviour.
Dr Claire Brand, Researcher in Canine Welfare at the RVC said: “Despite many owners’ concerted efforts to raise their puppies as well as possible, some puppies missed out on key experiences of puppyhood, such as going to puppy classes, or experiencing visitors in their homes.
"This has potential consequences for the future behaviour of ‘pandemic puppies’ and so we are encouraging owners to seek out training and behaviour advice from accredited professionals so that these now adult dogs can learn to live happily in our post-lockdown world.”
The 1CPD homepage now displays two progress bars: one to track the number of CPD hours currently achieved and recorded, and another to show how many hours have been reflected on.
Once the number of required CPD hours has been recorded and reflected on, a message appears to tell the user that they're CPD compliant.
This change will not affect existing CPD records, and all previously inputted activities and reflections will remain in the system.
Jenny Soreskog-Turp, RCVS Lead for Postgraduate Education, said: “We hope that the changes to the 1CPD platform will allow people to track their CPD more easily.
"A key element in outcomes-focused CPD includes reflecting on what you have learned as this is known to have a positive impact on both personal professionalism and patient-health outcomes.
“It should be noted that any CPD you have already undertaken for this year but have not yet reflected on will still remain in the system.
"However, in order to be compliant for 2023, you must reflect on every CPD activity completed.
"If you have completed your hours but have not reflected, this will show as non-compliant.
"In order to make those hours count, you simply need to go back and add your reflections.
"This doesn’t have to be a long and onerous task – uploading audio notes, adding an attachment, or writing a few notes stating what you learnt and how you will use this newly acquired knowledge moving forward will all suffice.”
www.rcvs.org.uk/cpd
However, when asked by VetSurgeon.org which audience - veterinary professionals, it's staff or the public - it was referring to, or what threats to safety and wellbeing were posed by X, the College refused point blank to answer.
So the real motivation remains unclear.
On the one hand, it could be a ridiculously over-sensitive move to protect its unknown audience from opinions that its staff find objectionable.
On the other hand, it could perfectly well be argued that short form social media reduces every discussion or debate to "I'm effing right and you're effing wrong", which is not appropriate for a scientific profession.
Equally, one could also argue that engaging in polarised debate online is not terribly good for one's wellbeing.
Or one could just argue that it's a terrible platform owned by a strangely meddlesome and interfering American.
However, given the College's strange refusal to expand on the reasons for its withdrawal, the first explanation seems more likely.
But who knows?
https://www.rcvs.org.uk/news-and-views/news/rcvs-statement-on-x-formerly-twitter/
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
The RCVS Charitable Trust has released the results of a survey that suggests a lack of available, high-quality research could be hampering the implementation of evidence-based medicine (EVM) in veterinary practice.
Of the 70 survey respondents, although 70% said they were familiar with the concepts of EVM, only 36% said that they always used EVM principles or that EVM principles were deeply embedded within their practices. When asked about the barriers to implementing EVM, many vets commented that there was a lack of high-quality research available to them.
Trust director, Cherry Bushell said: "This survey was relatively small as our intention is for it to help spark discussion at our forthcoming symposium 'The Sceptical Vet: Eminence or Evidence? Finding the best way forward for the veterinary profession'. We want to consider the possibility of developing a range of evidence-based resources for the veterinary profession, so it's interesting to hear vets commenting about the lack of an available, high-quality evidence base."
All those completing the Trust's survey were entered into a prize draw for a chance to have their travel expenses to the event reimbursed. Veterinary surgeon Ariel Brunn (top right) from Vets Now, Maidenhead, was the winner. She said: "I'm really looking forward to this Symposium and the discussion that will come with it - along with clinical governance, evidence-based practice provides a means to offer the best care for our veterinary patients. Having been a practising vet for less than 5 years, I'm excited to learn more about how EVM can be incorporated into veterinary practice and I'm certainly pleased to have won the prize draw to support my travel to this event."
This symposium will take place on Tuesday 30 October 2012, at Church House Conference Centre, London. A limited number of places are still available for practising veterinary surgeons and veterinary nurses only via the Trust (a.doorly@rcvstrust.org.uk or 0207 202 0741). For more information visit http://trust.rcvs.org.uk/grants-and-collaborations/the-sceptical-vet-eminence-or-evidence.
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life and that the onset of immunity for BRSV is 6 days (for calves vaccinated from the day of birth onwards) and 5 days (for calves vaccinated from the age of one week onwards).
Onset of immunity for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.
From a practical standpoint, the new license means Bovilis Intranasal RSP Live can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements.
Additionally, Bovilis Intranasal RSP Live can be used up to six hours after mixing with the solvent, which MSD says is the longest of all the available intranasal vaccines for these pathogens.
The vaccine is supplied as a nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.
The vaccine is available in 5x1 dose, 5 dose and 5x5 dose packs.
Certified B Corps are companies that meet exceptionally high standards of social and environmental performance, transparency and accountability.
The process examines a company’s full range of processes, from supply chain to charitable giving and employee benefits.
Other well-known names that have achieved B Corp status include Patagonia, The Body Shop, BrewDog, TOMS, Ben and Jerry’s and Innocent Drinks.
Dr Caroline Collins, from Pennard Vets, said: “We’re extremely proud to achieve B Corp status and there’s no doubt that it will be transformational for the business, in the same way that becoming an employment ownership trust has been.
"Being employee owned and socially minded is a huge draw for vets and nurses seeking a change in their career, who want to be part of an organisation where they can have a real say in the running of the practice and make a tangible difference to the environment.
“It also means that we can now make very long-term decisions, that could even take several decades to pay off, which would be very difficult to do in a traditional shareholder business, and that gives our team the authority to always do the right thing.”
Phovia is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
When used together they produce light of varying wavelengths that penetrates the skin to different depths, which Vetoquinol says helps to control bacteria and reduce inflammation on the surface of the skin and stimulates regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
After diagnosis and subsequent recommendation by a veterinary surgeon, any trained member of the clinical team can use Phovia.
For the study, which was led by Dr. Andrea Marchegiani, nine female dogs that had undergone unilateral or bilateral mastectomy for mammary neoplasia had half their wounds treated with FLE, whilst the other half served as the control and received no FLE.
To assess the potential benefits of FLE in reducing infection risk, swabs were taken for culture and sensitivity three, five and seven days after surgery.
The swabs from all FLE-managed wound portions showed no bacterial growth, in contrast to the control wounds, in which three dogs had positive culture results.
Andrea said: “For many reasons healing of surgical wounds can become challenging, especially after removal of mammary gland lumps.
"Veterinary clinicians have to face the three-fold challenge of meeting owner expectations of prompt and trouble-free wound healing, recognising those wounds in which healing may be prolonged or impaired and also following the principles of antibiotic stewardship.”
The study concluded that the research underscores the value of Phovia as a significant adjunct to conventional postoperative care in veterinary medicine, offering the dual benefits of reducing potential infection risks and lessening the home care burden for pet owners.
FLE’s application could potentially replace certain topical treatments and improve overall compliance by simplifying the administration of home therapies, thereby relieving pet owners of some responsibilities associated with postoperative care.
https://www.mdpi.com/2076-2615/14/8/1250